Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
33.95
-0.87 (-2.50%)
At close: Jul 31, 2025, 4:00 PM
34.55
+0.60 (1.77%)
After-hours: Jul 31, 2025, 4:49 PM EDT
Vaxcyte Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2020 |
Cash & Equivalents | 346.85 | 387.88 | 397.45 | 834.66 | 68.99 | 386.2 | Upgrade |
Short-Term Investments | 1,325 | 1,359 | 682.78 | 96.72 | 176.99 | - | Upgrade |
Cash & Short-Term Investments | 1,672 | 1,747 | 1,080 | 931.38 | 245.97 | 386.2 | Upgrade |
Cash Growth | 12.46% | 61.75% | 15.98% | 278.65% | -36.31% | 554.84% | Upgrade |
Other Receivables | - | 20.66 | 3.6 | 3.88 | 1.2 | 0.3 | Upgrade |
Receivables | - | 20.66 | 3.6 | 3.88 | 1.2 | 0.3 | Upgrade |
Prepaid Expenses | 44.83 | 15.73 | 6.16 | 5.31 | 9.18 | 2.5 | Upgrade |
Other Current Assets | - | 4.38 | 5.97 | 1.99 | - | - | Upgrade |
Total Current Assets | 1,717 | 1,788 | 1,096 | 942.56 | 256.35 | 389 | Upgrade |
Property, Plant & Equipment | 304.91 | 270.15 | 110.62 | 31.65 | 35.91 | 3.27 | Upgrade |
Long-Term Investments | 1,279 | 1,388 | 162.68 | 26.55 | 27.12 | - | Upgrade |
Long-Term Deferred Charges | - | - | - | - | 0.5 | 0.1 | Upgrade |
Other Long-Term Assets | 77.6 | 65.68 | 38.67 | 5.43 | 4.46 | 0.45 | Upgrade |
Total Assets | 3,378 | 3,511 | 1,408 | 1,006 | 324.34 | 392.83 | Upgrade |
Accounts Payable | 20.51 | 48.45 | 14.59 | 9.8 | 6.76 | 29.79 | Upgrade |
Accrued Expenses | 70.35 | 85.84 | 123.64 | 24.82 | 16.68 | 17.06 | Upgrade |
Current Portion of Leases | 6.13 | 5.89 | 7.11 | 5.91 | 5.28 | - | Upgrade |
Other Current Liabilities | - | - | - | - | - | 0.01 | Upgrade |
Total Current Liabilities | 97 | 140.18 | 145.34 | 40.53 | 28.72 | 46.86 | Upgrade |
Long-Term Leases | 81.08 | 65.22 | 22.11 | 12.03 | 11.51 | - | Upgrade |
Other Long-Term Liabilities | - | 0.1 | - | 0.01 | 0.1 | 0.12 | Upgrade |
Total Liabilities | 178.08 | 205.5 | 167.45 | 52.57 | 40.32 | 46.98 | Upgrade |
Common Stock | 0.13 | 0.13 | 0.1 | 0.08 | 0.06 | 0.05 | Upgrade |
Additional Paid-In Capital | 4,729 | 4,698 | 2,165 | 1,476 | 582.84 | 544.35 | Upgrade |
Retained Earnings | -1,529 | -1,388 | -924.39 | -522.13 | -298.64 | -198.56 | Upgrade |
Comprehensive Income & Other | -0.32 | -3.87 | 0.18 | -0.36 | -0.24 | - | Upgrade |
Total Common Equity | 3,200 | 3,306 | 1,240 | 953.61 | 284.02 | 345.84 | Upgrade |
Shareholders' Equity | 3,200 | 3,306 | 1,240 | 953.61 | 284.02 | 345.84 | Upgrade |
Total Liabilities & Equity | 3,378 | 3,511 | 1,408 | 1,006 | 324.34 | 392.83 | Upgrade |
Total Debt | 87.21 | 71.11 | 29.22 | 17.94 | 16.78 | - | Upgrade |
Net Cash (Debt) | 1,585 | 1,676 | 1,051 | 913.44 | 229.19 | 386.2 | Upgrade |
Net Cash Growth | 8.60% | 59.48% | 15.06% | 298.55% | -40.66% | 556.63% | Upgrade |
Net Cash Per Share | 12.38 | 13.74 | 10.82 | 14.08 | 4.41 | 13.07 | Upgrade |
Filing Date Shares Outstanding | 129 | 128.76 | 108.41 | 80.03 | 56.31 | 51.33 | Upgrade |
Total Common Shares Outstanding | 128.94 | 124.89 | 95.36 | 79.47 | 53.03 | 51.07 | Upgrade |
Working Capital | 1,620 | 1,648 | 950.62 | 902.03 | 227.63 | 342.14 | Upgrade |
Book Value Per Share | 24.82 | 26.47 | 13.01 | 12.00 | 5.36 | 6.77 | Upgrade |
Tangible Book Value | 3,200 | 3,306 | 1,240 | 953.61 | 284.02 | 345.84 | Upgrade |
Tangible Book Value Per Share | 24.82 | 26.47 | 13.01 | 12.00 | 5.36 | 6.77 | Upgrade |
Machinery | - | 58.15 | 35.62 | 15.12 | 11.5 | 5.25 | Upgrade |
Construction In Progress | - | 151.79 | 51.82 | - | - | 0.22 | Upgrade |
Leasehold Improvements | - | 4.38 | 1.46 | 1.35 | - | 1.9 | Upgrade |
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.